It's worth mentioning that there is some good news on the horizon here. Bad Pharma has prompted the UK government into action (ok, proposals of action) on unpub

It's worth mentioning that there is some good news on the horizon here. Bad Pharma has prompted the UK government into action (ok, proposals of action) on unpublished trials: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267966/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267966/ And more recently, the proposed UK copyright reform - also expected to become legislation in the next year - included a specific fair dealing right for data mining on journals, like the work of Ionnadis. The publishers had been arguing that this was a separate right from reading (which the researchers have already paid for) http://www.out-law.com/en/articles/2012/june/publishers-and-researchers-clash-over-data-mining-copyright-exception/ http://www.out-law.com/en/articles/2012/june/publishers-and-... (link is to discussion of the older Hargreaves report; the exception made it into the final proposal)